Development
GE HealthCare Technologies Inc.
GEHC
$71.62
$0.070.10%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 5.43% | 5.38% | 7.43% | 8.38% | 7.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.43% | 5.38% | 7.43% | 8.38% | 7.61% |
| Cost of Revenue | 1.46% | 3.00% | 7.03% | 5.67% | 10.23% |
| Gross Profit | 11.59% | 9.14% | 8.02% | 12.69% | 3.76% |
| SG&A Expenses | 12.95% | -2.98% | 7.28% | 4.20% | -3.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.86% | 3.00% | 7.69% | 5.79% | 7.61% |
| Operating Income | 8.45% | 20.92% | 5.85% | 27.79% | 7.58% |
| Income Before Tax | -15.18% | 2.25% | -10.80% | 2.44% | -4.90% |
| Income Tax Expenses | 27.81% | 93.80% | -10.46% | 24.43% | -15.64% |
| Earnings from Continuing Operations | -26.63% | -21.70% | -10.91% | -4.73% | -1.56% |
| Earnings from Discontinued Operations | -100.00% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 31.58% | -16.67% | -15.38% | 15.38% | -58.33% |
| Net Income | -27.26% | -23.00% | -13.81% | -4.37% | -1.77% |
| EBIT | 8.45% | 20.92% | 5.85% | 27.79% | 7.58% |
| EBITDA | 5.65% | 15.65% | 4.56% | 20.90% | 6.59% |
| EPS Basic | -27.42% | -23.17% | -14.00% | -51.52% | -- |
| Normalized Basic EPS | -17.11% | 4.57% | -11.87% | 2.94% | -- |
| EPS Diluted | -27.89% | -23.24% | -14.67% | -51.52% | -- |
| Normalized Diluted EPS | -17.65% | 3.88% | -12.44% | 2.27% | -- |
| Average Basic Shares Outstanding | 0.22% | 0.22% | 0.22% | 0.22% | -- |
| Average Diluted Shares Outstanding | 0.88% | 0.88% | 0.88% | 0.88% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |